Thursday, July 25, 2013

Dr. Michael Breen: One Stop CRPS CALMARE Treatment and Obstetrics/Gynecological Needs!

Michael Breen M.D. is not licensed to practice medicine in Illinois, though he touts " F-D-A Cleared Non-Invasive Pain Treatment Arrives In Illinois."

The FDA claim is an exagerration, and is a tired one.  CALMARE / CTTC applied to the FDA for permission to market itself as a "TENS" device.

He is, however, licensed as an obstetrician and gynecologist in Texas.  Like Dr. D'Amato of Rhode Island, and Dr. Robert Chalmers, also OB/Gyn specialists. An odd trend.

But it's a refreshing difference from, say Dr. Cooney, a chiropractor.

Returning to the FDA claim:

This is a copy of what Competitive Technologies submitted to the FDA as part of the requirement for 510(k) Premarket Notification.  I think the company's own application answers quite a few questions!

Device Classification Name:  stimulator, nerve, transcutaneous, for pain relief
Regulation Description:  Transcutaneous electrical nerve stimulator for pain relief

510(k) Number: K081255 
49 plain st.
north attleboro, MA 02760 2

Contact:  mary mcnamara
Regulation Number:  882.5890
Classification Product Code:  GZJ 
Date Received:  05/02/2008
Decision Date:  02/20/2009
Decision:  substantially equivalent (SE)
Classification Advisory Committee:  Neurology 
Review Advisory Committee:  Orthopedic 
Type: Traditional 
Reviewed by Third Party:  No 
Expedited Review:  No

From the FDA website:  

Section 510(k) of the Food, Drug and Cosmetic Act requires those device manufacturers who must register to notify FDA their intent to market a medical device. This is known as Premarket Notification (PMN) or 510(k). Under 510(k), before a manufacturer can market a medical device in the United States, they must demonstrate to FDA’s satisfaction that it is substantially equivalent (as safe and effective) to a device already on the market. If FDA rules the device is "substantially equivalent," the manufacturer can market the device. If the device you are researching has been in commercial distribution before 1976 or is substantially equivalent to a device already on the market, you should search FDA’s 510(k) releasable database.
So the irony is that the company claimed and was deemed, in fact, to have "substantial equivalence" to preexisting TENS devices... But now it wants to distance itself from any comparison to TENS technology.  


© 2013 L. Ryan

No comments:

Post a Comment

The Haddock Corporation's newest dictate: Anonymous comments are no longer allowed. It is easy enough to register and just takes a moment. We look forward to hearing from you non-bots and non-spammers!